P. Kent Hawryluk
President & CEO · MBX Biosciences, Inc.
- 2025
- May 8, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies P. Kent Hawryluk files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Salomon Azoulay - $2.72M in MBX purchases and sales in the last 12 months
- Steven L. Hoerter - $265K in MBX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is P. Kent Hawryluk?
P. Kent Hawryluk is a corporate insider, tracked as President & CEO of MBX Biosciences, Inc. (MBX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did P. Kent Hawryluk last file a Form 4?
The most recent primary Form 4 on record is dated 8 May 2026, one of 6 filings going back to 2025.
Has P. Kent Hawryluk been buying or selling stock?
Recorded transactions: 2 open-market purchases ($798K) and 1 open-market sale ($18K) across all tracked filings.
